Mark B. Meads
Moffitt Cancer Center(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Cancer Mechanisms and Therapy, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Environment-mediated drug resistance: a major contributor to minimal residual disease(2009)852 cited
- → The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance(2008)514 cited
- → β1 Integrin Adhesion Enhances IL-6–Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation(2009)198 cited
- → Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma(2017)148 cited
- → XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma(2016)89 cited
- → Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors(2016)82 cited
- → BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models(2019)80 cited
- → Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma(2015)73 cited
- → An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma(2017)68 cited
- → Kaposi's Sarcoma-associated Herpesvirus-encoded Viral Interleukin-6 Is Secreted and Modified Differently Than Human Interleukin-6(2004)63 cited